I-Mab to Participate at the 23rd Annual Needham Virtual Healthcare Conference
I-Mab to Participate at the 23rd Annual Needham Virtual Healthcare Conference
ROCKVILLE, Md., April 5, 2024 /PRNewswire/ -- I-Mab (NASDAQ: IMAB), a U.S.-based, global biotech company, exclusively focused on the development and potential commercialization of highly differentiated immunotherapies for the treatment of cancer, today announced that management will present at the 23rd Annual Needham Virtual Healthcare Conference on April 11, 2024.
马里兰州罗克维尔，2024年4月5日 /PRNewswire/ — 总部位于美国的全球生物技术公司I-Mab（纳斯达克股票代码：IMAB）今天宣布，管理层将出席第二十三届会议，该公司专门研究治疗癌症的高差异化免疫疗法的开发和潜在商业化第三方 2024 年 4 月 11 日举行的年度尼德姆虚拟医疗保健会议。
23rd Annual Needham Virtual Healthcare Conference
23第三方 年度 Needham 虚拟医疗会议
| Presentation Time | Thursday, April 11 at 10:15 a.m. EST |
| Presenters | Raj Kannan, CEO; John Hayslip CMO |
| Webcast link | |
| Meetings | One-on-one and small group meetings: April 11, 2024 |
| Management | Raj Kannan, CEO Joe Skelton, CFO John Hayslip, CMO |
| 演示时间 | 美国东部标准时间4月11日星期四上午10点15分 |
| 演示者 | 首席执行官拉吉·坎南；约翰·海斯利普首席营销官 |
| 网络直播链接 | |
| 会议 | 一对一和小组会议：2024 年 4 月 11 日 |
| 管理 | 首席执行官拉吉·坎南 首席财务官乔·斯凯尔顿 首席营销官约翰·海斯利普 |
The webcast will also be available under "Event Calendar" on I-Mab's IR website
at http://ir.i-mabbiopharma.com/
网络直播还将在 I-Mab 投资者关系网站上的 “活动日历” 下播出
在 http://ir.i-mabbiopharma.com/
For more information, please contact your Needham representative.
欲了解更多信息，请联系您的 Needham 代表。
About I-Mab
关于 i-Mab
I-Mab (NASDAQ: IMAB) is a U.S.-based, global biotech company, exclusively focused on the development and potential commercialization of highly differentiated immunotherapies for the treatment of cancer. I-Mab has established operations in Rockville, Maryland, and in San Diego, California. For more information, please visit http://www.i-mabbiopharma.com and follow us on LinkedIn and X.
I-Mab（纳斯达克股票代码：IMAB）是一家总部位于美国的全球生物技术公司，专门致力于治疗癌症的高差异化免疫疗法的开发和潜在商业化。I-Mab 已在马里兰州罗克维尔和加利福尼亚州圣地亚哥开展业务。欲了解更多信息，请访问 http://www.i-mabbiopharma.com 然后在 LinkedIn 和 X 上关注我们。
For more information, please contact:
Tyler Ehler
Senior Director, Investor Relations
IR@imabbio.com
欲了解更多信息，请联系：
泰勒·埃勒
投资者关系高级董事
IR@imabbio.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/i-mab-to-participate-at-the-23rd-annual-needham-virtual-healthcare-conference-302108935.html
SOURCE I-Mab Biopharma
来源 I-Mab Biopharma